Merlin Capital LLC Intellia Therapeutics, Inc. Transaction History
Merlin Capital LLC
- $32.2 Million
- Q1 2024
A detailed history of Merlin Capital LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Merlin Capital LLC holds 17,724 shares of NTLA stock, worth $273,481. This represents 1.51% of its overall portfolio holdings.
Number of Shares
17,724
Previous 26,834
33.95%
Holding current value
$273,481
Previous $818,000
40.46%
% of portfolio
1.51%
Previous 2.41%
Shares
11 transactions
Others Institutions Holding NTLA
# of Institutions
320Shares Held
88.4MCall Options Held
673KPut Options Held
865K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.3MShares$189 Million2.39% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$148 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.1MShares$140 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.8MShares$74.1 Million3.53% of portfolio
-
State Street Corp Boston, MA4.36MShares$67.3 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.17B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...